Probiotics in critically ill children

F1000Research

Volumn 5, Issue , 2016, Pages

  Singhi, Sunit C ^a   Kumar, Suresh ^b  

^a MAHARISHI MARKANDESHWAR INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ANTIBIOTIC ASSOCIATED DIARRHEA; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; CANDIDA; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; CHILD; CRITICAL ILLNESS; CYTOKINE PRODUCTION; DRUG SAFETY; ENDOTOXEMIA; FUNGAL COLONIZATION; FUNGEMIA; HEALTHCARE ASSOCIATED INFECTION; HEMORRHAGIC SHOCK; HUMAN; IMMUNOCOMPROMIZED PATIENT; INTESTINE FLORA; INVASIVE CANDIDIASIS; LACTOBACILLUS; LIVER ABSCESS; MUCOSAL IMMUNITY; NECROTIZING ENTEROCOLITIS; NONHUMAN; PREMATURITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VENTILATOR ASSOCIATED PNEUMONIA; VERY LOW BIRTH WEIGHT;

EID: 84964617179     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.7630.1     Document Type: Article

References (83)

1. Marshall JC Christou NV Meakins JL: The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann Surg. 1993;218(2):111-9. 8342990 10.1097/00000658-199308000-00001 1242919
2. Alverdy JC Laughlin RS Wu L: Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined. Crit Care Med. 2003;31(2):598-607. 12576972 10.1097/01.CCM.0000045576.55937.67
3. Singhi SC Baranwal A: Probiotic use in the critically ill. Indian J Pediatr. 2008;75(6):621-7. 18759092 10.1007/s12098-008-0119-1
4. Lilly DM Stillwell RH: Probiotics: growth-promoting factors produced by microorganisms. Science. 1965;147(3659):747-8. 14242024 10.1126/science.147.3659.747
5. Guarner F Malagelada JR: Gut flora in health and disease. Lancet. 2003;361(9356):512-9. 12583961 10.1016/S0140-6736(03)12489-0
6. Andersson R Wang X Ihse I: The influence of abdominal sepsis on acute pancreatitis in rats: a study on mortality, permeability, arterial pressure, and intestinal blood flow. Pancreas. 1995;11(4):365-73. 8532653
7. Leveau P Wang X Soltesz V: Alterations in intestinal motility and microflora in experimental acute pancreatitis. Int J Pancreatol. 1996;20(2):119-25. 8968867
8. Wang X Andersson R Soltesz V: Gut origin sepsis, macrophage function, and oxygen extraction associated with acute pancreatitis in the rat. World J Surg. 1996;20(3):299-307; discussion 307-8. 8661835 10.1007/s002689900048
9. Shimizu K Ogura H Goto M: Altered gut flora and environment in patients with severe SIRS. J Trauma. 2006;60(1):126-33. 16456446 10.1097/01.ta.0000197374.99755.fe
10. MacFie J O'Boyle C Mitchell CJ: Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut. 1999;45(2):223-8. 10403734 10.1136/gut.45.2.223 1727620
11. Kligler B Cohrssen A: Probiotics. Am Fam Physician. 2008;78(9):1073-8. 19007054
12. Bengmark S: Bioecologic control of the gastrointestinal tract: the role of flora and supplemented probiotics and synbiotics. Gastroenterol Clin North Am. 2005;34(3):413-36, viii. 16084305 10.1016/j.gtc.2005.05.002
13. Chermesh I Eliakim R: Probiotics and the gastrointestinal tract: where are we in 2005? World J Gastroenterol. 2006;12(6):853-7. 16521211 10.3748/wjg.v12.i6.853 4066148
14. Kumar S Singhi S: Role of probiotics in prevention of Candida infection in critically ill children. Mycoses. 2013;56(3):204-11. 23176162 10.1111/myc.12021
15. Buts JP Bernasconi P Vaerman JP: Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci. 1990;35(2):251-6. 2302983 10.1007/BF01536771
16. Vandenplas Y Huys G Daube G: Probiotics: an update. J Pediatr (Rio J). 2015;91(1):6-21. 25458874 10.1016/j.jped.2014.08.005
17. Hoyos AB: Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis. 1999;3(4):197-202. 10575148 10.1016/S1201-9712(99)90024-3
18. Dani C Biadaioli R Bertini G: Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate. 2002;82(2):103-8. 12169832 10.1159/000063096
19. Lin HC Su BH Chen AC: Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2005;115(1):1-4. 15629973
20. Bin-Nun A Bromiker R Wilschanski M: Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr. 2005;147(2):192-6. 16126048 10.1016/j.jpeds.2005.03.054
21. Alfaleh K Bassler D: Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2008; (1):CD005496. 18254081 10.1002/14651858.CD005496.pub2
22. AlFaleh K Anabrees J: Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2014;4:CD005496. 24723255 10.1002/14651858.CD005496.pub4 F1000 Recommendation
23. Beaugerie L Petit JC: Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract Res Clin Gastroenterol. 2004;18(2):337-52. 15123074 10.1016/j.bpg.2003.10.002
24. Kotzampassi K Giamarellos-Bourboulis EJ Voudouris A: Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial. World J Surg. 2006;30(10):1848-55. 16983476 10.1007/s00268-005-0653-1
25. Watkinson PJ Barber VS Dark P: The use of pre- pro- and synbiotics in adult intensive care unit patients: systematic review. Clin Nutr. 2007;26(2):182-92. 17011083 10.1016/j.clnu.2006.07.010
26. Liu KX Zhu YG Zhang J: Probiotics' effects on the incidence of nosocomial pneumonia in critically ill patients: a systematic review and meta-analysis. Crit Care. 2012;16(3):R109. 22731894 10.1186/cc11398 3580667 F1000 Recommendation
27. Petrof EO Dhaliwal R Manzanares W: Probiotics in the critically ill: a systematic review of the randomized trial evidence. Crit Care Med. 2012;40(12):3290-302. 22975886 10.1097/CCM.0b013e318260cc33 F1000 Recommendation
28. Bo L Li J Tao T: Probiotics for preventing ventilator-associated pneumonia. Cochrane Database Syst Rev. 2014;10:CD009066. 25344083 10.1002/14651858.CD009066.pub2 4283465 F1000 Recommendation
29. Honeycutt TC El Khashab M Wardrop RM 3rd: Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial. Pediatr Crit Care Med. 2007;8(5):452-8; quiz 464. 17693918 10.1097/01.PCC.0000282176.41134.E6
30. Wang Y Gao L Zhang YH: Efficacy of probiotic therapy in full-term infants with critical illness. Asia Pac J Clin Nutr. 2014;23(4):575-80. 25516315 10.6133/apjcn.2014.23.4.14 F1000 Recommendation
31. Banupriya B Biswal N Srinivasaraghavan R: Probiotic prophylaxis to prevent ventilator associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial. Intensive Care Med. 2015;41(4):677-85. 25708419 10.1007/s00134-015-3694-4 F1000 Recommendation
32. Manzoni P Mostert M Leonessa ML: Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis. 2006;42(12):1735-42. 16705580 10.1086/504324
33. Romeo MG Romeo DM Trovato L: Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol. 2011;31(1):63-9. 20410904 10.1038/jp.2010.57 3016918 F1000 Recommendation
34. Demirel G Celik IH Erdeve O: Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants. Eur J Pediatr. 2013;172(10):1321-6. 23703468 10.1007/s00431-013-2041-4 F1000 Recommendation
35. Roy A Chaudhuri J Sarkar D: Role of Enteric Supplementation of Probiotics on Late-onset Sepsis by Candida species in Preterm Low Birth Weight Neonates: A Randomized, Double Blind, Placebo-controlled Trial. N Am J Med Sci. 2014;6(1):50-7. 24678479 10.4103/1947-2714.125870 3938875 F1000 Recommendation
36. Oncel MY Arayici S Sari FN: Comparison of Lactobacillus reuteri and nystatin prophylaxis on Candida colonization and infection in very low birth weight infants. J Matern Fetal Neonatal Med. 2015;28(15):1790-4. 25245226 10.3109/14767058.2014.968842 F1000 Recommendation
37. Kumar S Bansal A Chakrabarti A: Evaluation of efficacy of probiotics in prevention of candida colonization in a PICU-a randomized controlled trial. Crit Care Med. 2013;41(2):565-72. 23361033 10.1097/CCM.0b013e31826a409c F1000 Recommendation
38. Kumar S Singhi S Chakrabarti A: Probiotic use and prevalence of candidemia and candiduria in a PICU. Pediatr Crit Care Med. 2013;14(9):e409-15. 23965638 10.1097/PCC.0b013e31829f5d88
39. Jiang Q Stamatova I Kari K: Inhibitory activity in vitro of probiotic lactobacilli against oral Candida under different fermentation conditions. Benef Microbes. 2015;6(3):361-8. 25380800 10.3920/BM2014.0054 F1000 Recommendation
40. Cannon JP Lee TA Bolanos JT: Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis. 2005;24(1):31-40. 15599646 10.1007/s10096-004-1253-y
41. Rautio M Jousimies-Somer H Kauma H: Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis. 1999;28(5):1159-60. 10452653 10.1086/514766
42. Horwitch CA Furseth HA Larson AM: Lactobacillemia in three patients with AIDS. Clin Infect Dis. 1995;21(6):1460-2. 8749632 10.1093/clinids/21.6.1460
43. Mackay AD Taylor MB Kibbler CC: Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect. 1999;5(5):290-2. 11856270 10.1111/j.1469-0691.1999.tb00144.x
44. Salminen MK Rautelin H Tynkkynen S: Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis. 2004;38(1):62-9. 14679449 10.1086/380455
45. Salvana EM Frank M: Lactobacillus endocarditis: case report and review of cases reported since 1992. J Infect. 2006;53(1):e5-e10. 16307799 10.1016/j.jinf.2005.10.005
46. Vahabnezhad E Mochon AB Wozniak LJ: Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J Clin Gastroenterol. 2013;47(5):437-9. 23426446 10.1097/MCG.0b013e318279abf0
47. Kunz AN Noel JM Fairchok MP: Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr. 2004;38(4):457-8. 15085028 10.1097/00005176-200404000-00017
48. Land MH Rouster-Stevens K Woods CR: Lactobacillus sepsis associated with probiotic therapy. Pediatrics. 2005;115(1):178-81. 15629999
49. Salminen MK Tynkkynen S Rautelin H: Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis. 2002;35(10):1155-60. 12410474 10.1086/342912
50. Hennequin C Kauffmann-Lacroix C Jobert A: Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis. 2000;19(1):16-20. 10706174 10.1007/s100960050003
51. Lestin F Pertschy A Rimek D: [Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities]. Dtsch Med Wochenschr. 2003;128(48):2531-3. 14648435 10.1055/s-2003-44948
52. Muñoz P Bouza E Cuenca-Estrella M: Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis. 2005;40(11):1625-34. 15889360 10.1086/429916
53. Bertelli C Pillonel T Torregrossa A: Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis. 2015;60(6):924-7. 25472946 10.1093/cid/ciu946 F1000 Recommendation
54. Zbinden A Zbinden R Berger C: Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology. 2015;107(1):56-9. 25402825 10.1159/000367985 F1000 Recommendation
55. Manzoni P Lista G Gallo E: Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study. Early Hum Dev. 2011;87(Suppl 1):S35-8. 21295418 10.1016/j.earlhumdev.2011.01.036 F1000 Recommendation
56. Srinivasan R Meyer R Padmanabhan R: Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children. J Pediatr Gastroenterol Nutr. 2006;42(2):171-3. 16456410 10.1097/01.mpg.0000189335.62397.cf
57. Simakachorn N Bibiloni R Yimyaem P: Tolerance, safety, and effect on the faecal microbiota of an enteral formula supplemented with pre- and probiotics in critically ill children. J Pediatr Gastroenterol Nutr. 2011;53(2):174-81. 21788759 10.1097/MPG.0b013e318216f1ec F1000 Recommendation
58. Boyle RJ Robins-Browne RM Tang ML: Probiotic use in clinical practice: what are the risks? Am J Clin Nutr. 2006;83(6):1256-64; quiz 1446-7. 16762934
59. Egervärn M Danielsen M Roos S: Antibiotic susceptibility profiles of Lactobacillus reuteri and Lactobacillus fermentum. J Food Prot. 2007;70(2):412-8. 17340877
60. Egervärn M Roos S Lindmark H: Identification and characterization of antibiotic resistance genes in Lactobacillus reuteri and Lactobacillus plantarum. J Appl Microbiol. 2009;107(5):1658-68. 19457037 10.1111/j.1365-2672.2009.04352.x
61. Noverr MC Huffnagle GB: The 'microflora hypothesis' of allergic diseases. Clin Exp Allergy. 2005;35(12):1511-20. 16393316 10.1111/j.1365-2222.2005.02379.x
62. Weinstein PD Cebra JJ: The preference for switching to IgA expression by Peyer's patch germinal center B cells is likely due to the intrinsic influence of their microenvironment. J Immunol. 1991;147(12):4126-35. 1753088
63. Corr SC Li Y Riedel CU: Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A. 2007;104(18):7617-21. 17456596 10.1073/pnas.0700440104 1863472
64. Roberfroid MB Bornet F Bouley C: Colonic microflora: nutrition and health. Summary and conclusions of an International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutr Rev. 1995;53(5):127-30. 7666984 10.1111/j.1753-4887.1995.tb01535.x
65. Conly JM Stein K Worobetz L: The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol. 1994;89(6):915-23. 8198105
66. Younes H Coudray C Bellanger J: Effects of two fermentable carbohydrates (inulin and resistant starch) and their combination on calcium and magnesium balance in rats. Br J Nutr. 2001;86(4):479-85. 11591235 10.1079/BJN2001430
67. Machairas N Pistiki A Droggiti DI: Pre-treatment with probiotics prolongs survival after experimental infection by multidrug-resistant Pseudomonas aeruginosa in rodents: an effect on sepsis-induced immunosuppression. Int J Antimicrob Agents. 2015;45(4):376-84. 25601531 10.1016/j.ijantimicag.2014.11.013 F1000 Recommendation
68. Mangell P Lennernäs P Wang M: Adhesive capability of Lactobacillus plantarum 299v is important for preventing bacterial translocation in endotoxemic rats. APMIS. 2006;114(9):611-8. 16948813 10.1111/j.1600-0463.2006.apm_369.x
69. Ruan X Shi H Xia G: Encapsulated Bifidobacteria reduced bacterial translocation in rats following hemorrhagic shock and resuscitation. Nutrition. 2007;23(10):754-61. 17706400 10.1016/j.nut.2007.07.002
70. Sánchez E Nieto JC Boullosa A: VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis. Liver Int. 2015;35(3):735-45. 24750552 10.1111/liv.12566 F1000 Recommendation
71. Shimizu K Ogura H Goto M: Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report. Dig Dis Sci. 2009;54(5):1071-8. 18726154 10.1007/s10620-008-0460-2
72. Hayakawa M Asahara T Ishitani T: Synbiotic therapy reduces the pathological gram-negative rods caused by an increased acetic acid concentration in the gut. Dig Dis Sci. 2012;57(10):2642-9. 22576712 10.1007/s10620-012-2201-9 F1000 Recommendation
73. Jain PK McNaught CE Anderson AD: Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr. 2004;23(4):467-75. 15297081 10.1016/j.clnu.2003.12.002
74. Mohan R Koebnick C Schildt J: Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J Clin Microbiol. 2006;44(11):4025-31. 16971641 10.1128/JCM.00767-06 1698302
75. Sanaie S Ebrahimi-Mameghani M Hamishehkar H: Effect of a multispecies probiotic on inflammatory markers in critically ill patients: A randomized, double-blind, placebo-controlled trial. J Res Med Sci. 2014;19(9):827-33. 25535496 4268190 F1000 Recommendation
76. McNaught CE Woodcock NP Anderson AD: A prospective randomised trial of probiotics in critically ill patients. Clin Nutr. 2005;24(2):211-9. 15784480 10.1016/j.clnu.2004.08.008
77. Ebrahimi-Mameghani M Sanaie S Mahmoodpoor A: Effect of a probiotic preparation (VSL#3) in critically ill patients: A randomized, double-blind, placebo-controlled trial (Pilot Study). Pak J Med Sci. 2013;29(2):490-4. 24353562 10.12669/pjms.292.3370 3809220 F1000 Recommendation
78. D'Souza AL Rajkumar C Cooke J: Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ. 2002;324(7350):1361. 12052801 10.1136/bmj.324.7350.1361 115209
79. Szajewska H Ruszczyński M Radzikowski A: Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr. 2006;149(3):367-72. 16939749 10.1016/j.jpeds.2006.04.053
80. Johnston BC Supina AL Vohra S: Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. CMAJ. 2006;175(4):377-83. 16908901 10.1503/cmaj.051603 1534112
81. Hempel S Newberry SJ Maher AR: Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307(18):1959-69. 22570464 10.1001/jama.2012.3507 F1000 Recommendation
82. Szajewska H Kołodziej M: Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2015;42(7):793-801. 26216624 10.1111/apt.13344 F1000 Recommendation
83. Szajewska H Kołodziej M: Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther. 2015;42(10):1149-57. 26365389 10.1111/apt.13404 F1000 Recommendation